Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1981-02-03
1982-05-18
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424311, 424320, 424324, A61K 31195, A61K 3116, A61K 3122, A61K 31165
Patent
active
043305598
ABSTRACT:
There is described a method for treating benign prostatic hypertrophy comprising the administration of 2,5-di-amino-2-(mono-,di-, or trifluoromethyl)pentanoic acid or derivative thereof.
REFERENCES:
patent: 2662915 (1953-12-01), Lowtz
Rawdo, Science, vol. 185, pp. 320-324 (7-26-1974).
Jof Men. Chem., vol. 17, No. 4, pp. 447-451 (1944).
Jof Med. Chem., vol 218, No. 4, pp. 600-604, 1975.
Burger, Medical Chem., 3rd Ed. Part I, 1970, pp. 65, 71 & 72.
Bey Philippe
Jung Michel
Frankhouser David E.
Goldberg Jerome D.
McDonald Raymond A.
Merrell-Toraude et Cie
Stein William J.
LandOfFree
Method of treating benign prostatic hypertrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating benign prostatic hypertrophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating benign prostatic hypertrophy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-486905